The Wada Test, 1948

A decades-old neurological procedure developed under unique and difficult conditions in postwar Japan remains critical to the treatment of epilepsy.

Written byPhil Jaekl
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

LANGUAGE AND MEMORY ASSESSMENT: Rebecca Rausch (far right), now a senior neurologist at the University of California, Los Angeles, is pictured here performing a modified version of the Wada test in the early 1970s. The patient is a candidate for epilepsy surgery to remove tissue from the brain hemisphere causing seizures. The test is required to determine if brain areas that underlie language and memory also reside in the same side of the brain. During the test, the patient names and recalls objects shown to him while an anesthetic—usually sodium amobarbital—is introduced to each hemisphere in turn. If linguistic deficits coincide with the anesthetization of the seizure-causing area, surgery will not be performed.© UCLAAs a medical student on the Japanese island of Hokkaido in the 1940s, Juhn Wada developed an interest in neurology, before “neurology” was formally a word and before dedicated departments existed anywhere in Japan. After completing his degree, Wada began researching electroconvulsive (“shock”) therapy, which works by inducing seizures—abnormal electrical activity in the brain. At that time, the procedure was becoming common for patients with severe depression or schizophrenia. The shocks, however, also caused language and memory impairments. Based on existing evidence showing that linguistic and, to a lesser extent, memory functioning predominantly take place in a single brain hemisphere, Wada proposed anesthetizing that hemisphere to avoid causing the impairments.

His proposed approach was highly criticized until 1948, when Wada learned of a patient who had developed persistent, uncontrollable seizures—a young cook at an American base camp who had been shot in the head by a drunken soldier attempting to shoot off his hat. As a last resort, the cook agreed to let Wada anesthetize his brain, one hemisphere at a time. Upon the injection of an anesthetic barbiturate into an artery known to deliver blood only to the left hemisphere, the man’s seizures were successfully controlled. But the side effects of the barbiturate treatment were startling and immediately apparent. According to his written account, chills ran up and down Wada’s spine as the patient temporarily lost all language ability and motor function on the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  •  Phil's writing has been featured in The Atlantic, Aeon, Knowable, The Guardian, and Nautilus magazine. He authored the book Out Cold: A Chilling Descent into the Macabre, Controversial, Lifesaving History of Hypothermia.

    View Full Profile

Published In

November 2017

The Mosaic Brain

Functional implications of a complex neural ecosystem

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform